A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)

Clinical trial NCT02411929 · COMPLETED

Trial details

NCT number: NCT02411929
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2014-10-29
Primary completion: 2015-01-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.